These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The contributions of molecular biology to cancer epidemiology. Weinstein IB Ann N Y Acad Sci; 1995 Sep; 768():30-40. PubMed ID: 8526372 [No Abstract] [Full Text] [Related]
24. [Molecular epidemiology of cancers and precancerous conditions]. Ember I; Kiss I; Sándor J; Varga C; Gyöngyi Z; Németh K; Fehér K; Lukács P; Dombi Z Orv Hetil; 2004 Mar; 145(10):507-14. PubMed ID: 15085589 [TBL] [Abstract][Full Text] [Related]
25. Molecular genetics and management strategies in hereditary cancer syndromes. Hanna NN; Mentzer RM J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901 [TBL] [Abstract][Full Text] [Related]
26. Integrative epidemiology: from risk assessment to outcome prediction. Spitz MR; Wu X; Mills G J Clin Oncol; 2005 Jan; 23(2):267-75. PubMed ID: 15637390 [TBL] [Abstract][Full Text] [Related]
27. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression. Malats N Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927 [TBL] [Abstract][Full Text] [Related]
28. What relevance do advances in molecular biology and genetics have for epidemiology: high tech needle and thread to sew the web of causation. Vegni FE Ann Ig; 1997; 9(4):273-9. PubMed ID: 9360327 [TBL] [Abstract][Full Text] [Related]
29. [Molecular epidemiology--applications in cancer research]. Hemminki K; Pershagen G Lakartidningen; 1992 Jul; 89(28-29):2434-6. PubMed ID: 1507961 [No Abstract] [Full Text] [Related]
30. Translational behavioral research in cancer genetics. Lerman C Prev Med; 1997; 26(5 Pt 2):S65-9. PubMed ID: 9327494 [TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology: new rules for new tools? Merlo DF; Sormani MP; Bruzzi P Mutat Res; 2006 Aug; 600(1-2):3-11. PubMed ID: 16843503 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing. Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664 [TBL] [Abstract][Full Text] [Related]
33. [Ethical legal and social issues in pre-symptomatic testing for cancer susceptibility in familial tumors]. Tsunematsu Y Gan To Kagaku Ryoho; 1997 Jun; 24(8):945-50. PubMed ID: 9212802 [TBL] [Abstract][Full Text] [Related]
34. The new era of cancer epidemiology. Correa P Cancer Epidemiol Biomarkers Prev; 1991; 1(1):5-11. PubMed ID: 1845169 [No Abstract] [Full Text] [Related]
35. [Patient without being ill? Benefit and risks of presymptomatic diagnosis]. Müller HJ Schweiz Rundsch Med Prax; 1993 Jan; 82(2):45-9. PubMed ID: 8424138 [TBL] [Abstract][Full Text] [Related]
39. Exploring family relationships in cancer risk counseling using the genogram. Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645 [TBL] [Abstract][Full Text] [Related]
40. Measures of genotype versus gene products: promise and pitfalls in cancer prevention. Ahsan H; Rundle AG Carcinogenesis; 2003 Sep; 24(9):1429-34. PubMed ID: 12819189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]